We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News   Mar 08, 2021 | Original story from NIH

 
NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial
 
 
Advertisement
 

RELATED ARTICLES

Baby's Response to Infectious Disease Impacted by Mother's Fat Intake

News

Researchers have determined that the type of fats a mother consumes while breastfeeding can have long-term implications on her infant's gut health.

READ MORE

Fragment Screen Points to New SARS-CoV-2 Inhibitors

News

A crystallographic fragment screen of the Nsp3 Mac1 protein provides a template for how to develop directly-acting antivirals with novel modes of action.

READ MORE

A Long-Acting Injectable Therapy To Treat COVID-19

News

University of Liverpool researchers have demonstrated the potential of repurposing an existing drug called niclosamide into a long-acting injectable therapy that could be used to treat COVID-19.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE